Pancreatitis: References

1. Patterson RE, Frank LL, Kristal AR, et al. A comprehensive examination of health conditions associated with obesity in older adults. Am J Prev Med. 2004;27:385–390.

2. Martinez J, Sanchez–Paya J, Palazon JM, et al. Is obesity a risk factor in acute pancreatitis? A meta–analysis. Pancreatology. 2004;4:42–48.

3. Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol. 2003;36:54–62.

4. O'Keefe JH Jr, Harris WS. From Inuit to implementation: omega–3 fatty acids come of age. Mayo Clin Proc. 2000;75:607–614.

5. Hellerstein MK. Carbohydrate–induced hypertriglyceridemia: modifying factors and implications for cardiovascular risk. Curr Opin Lipidol. 2002;13:33–40.

6. Parks EJ, Hellerstein MK. Carbohydrate–induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr. 2000;71:412–433.

7. Riccardi G, Rivellese AA. Dietary treatment of the metabolic syndrome––the optimal diet. Br J Nutr. 2000;83(suppl 1):S143–S148.

8. McCloy R. Chronic pancreatitis at Manchester, UK. Focus on antioxidant therapy. Digestion. 1998;59(suppl 4):36–48.

9. Cullen JJ, Mitros FA, Oberley LW. Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer. Pancreas. 2003;26:23–27.

10. Morris–Stiff GJ, Bowrey DJ, Oleesky D, et al. The antioxidant profiles of patients with recurrent acute and chronic pancreatitis. Am J Gastroenterol. 1999;94:2135–2140.

11. Bowrey DJ, Morris–Stiff GJ, Puntis MC. Selenium deficiency and chronic pancreatitis: disease mechanism and potential for therapy. HPB Surg. 1999;11:207–216.

12. Corrao G, Bagnardi V, Zambon A, et al. A meta–analysis of alcohol consumption and the risk of 15 diseases. Prev Med. 2004;38:613–619.

13. Morton C, Klatsky AL, Udaltsova N. Smoking, coffee, and pancreatitis. Am J Gastroenterol. 2004;99:731–738.

14. Koller EA, Cross JT, Doraiswamy PM, et al. Pancreatitis associated with atypical antipsychotics: from the Food and Drug Administration's MedWatch surveillance system and published reports. Pharmacotherapy. 2003;23:1123–1130.

15. Mantel–Teeuwisse AK, Kloosterman JM, Maitland–van der Zee AH, et al. Drug–Induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels. Drug Safety. 2001;24:443–456.

16. Barrett–Connor E. Postmenopausal estrogen therapy and selected (less–often–considered) disease